MORGAN STANLEY - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q2 2022. The put-call ratio across all filers is 10.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$3,799
-28.4%
2,404
-2.1%
0.00%
Q2 2023$5,303
+10.6%
2,455
+7.5%
0.00%
Q1 2023$4,7962,284
+3072.2%
0.00%
Q1 2022$0
-100.0%
72
-99.6%
0.00%
Q4 2021$153,000
+3725.0%
20,465
+1461.0%
0.00%
Q3 2020$4,000
-76.5%
1,311
-65.0%
0.00%
Q2 2020$17,0003,7440.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tikvah Management LLC 1,225,833$9,157,0002.55%
Stonepine Capital Management, LLC 525,531$3,926,0001.80%
Telemetry Investments, L.L.C. 176,782$1,321,0001.70%
TANG CAPITAL MANAGEMENT LLC 1,113,453$8,317,0001.67%
VR Adviser, LLC 1,565,000$11,691,0001.60%
Deep Track Capital, LP 1,100,000$8,217,0000.58%
EAM Investors, LLC 252,280$1,885,0000.31%
EAM Global Investors LLC 152,792$1,141,0000.20%
FEDERATED HERMES, INC. 5,222,250$39,010,0000.07%
Alyeska Investment Group, L.P. 674,975$5,042,0000.06%
View complete list of ATYR PHARMA INC shareholders